Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
Fuzhegn Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
Peking University First Hospital
144 participants
Oct 24, 2022
INTERVENTIONAL
Conditions
Summary
Fuzheng Nizeng Formula (FZNZ) is derived from the classic formula Liujunzi Decoction. Former pilot study found that FZNZ promoted the recovery of gastric atrophy and relieve the relative symptoms. This study is to evaluate its efficacy for chronic atrophic gastritis with low-grade intraepithelial neoplasia, compared with positive control Molduodan granule.
Eligibility
Inclusion Criteria3
- Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia diagnosed by endoscopy and stomach biopsy.
- Helicobacter pylori negative.
- TCM syndrome is spleen-stomach deficiency with blood stasis and phelgm.
Exclusion Criteria5
- History of gastric surgery.
- Combined with malignant tumor.
- History of mental illness.
- Allergy to any components of the drug use in the study.
- Planning to pregnancy, or pregnant woman and lactating woman.
Interventions
Subjects taking prepared Fuzhegn Nizeng granules twice daily for 6 month.
Subjects taking prepared Moluodan granules 9g twice daily for 6 month.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06324825